Rachael K. Ross, PhD, MPH, holds a PhD in epidemiology with a minor in biostatistics from the University of North Carolina and a Master's in Public Health from Emory University. Her applied research leverages real-world health data and clinical trial data to inform optimal and equitable treatment of opioid use disorder, in particular medication treatment including buprenorphine and methadone. Rachael has a K99R00 Pathway to Independence Award from NIDA (1K99DA061935). In this work she will examine real-world access to extended-release (long-acting) buprenorphine and to understand optimal use of the different buprenorphine formulations with the goal of producing evidence to support personalized and effective buprenorphine treatment decisions. In her methodological research, Rachael develops and evaluates causal inference methods related to missing data, measurement error, and transporting results to relevant real-world target populations. She is also passionate about the dissemination of methodological and statistical tools to a broad research audience. Prior to her PhD, Rachael worked for 7 years at the Children’s Hospital of Philadelphia conducting pharmacoepidemiology and health services research focused on antibiotic treatment in children.
